Accredited Investors’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,192
Closed -$316K 290
2025
Q4
$316K Sell
1,192
-79
-6% -$19.6K 0.02% 212
2025
Q3
$301K Sell
1,271
-25
-2% -$6.3K 0.02% 200
2025
Q2
$353K Buy
1,296
+93
+8% +$24.9K 0.02% 170
2025
Q1
$323K Sell
1,203
-25
-2% -$7.78K 0.02% 166
2024
Q4
$411K Sell
1,228
-390
-24% -$124K 0.02% 150
2024
Q3
$443K Buy
1,618
+689
+74% +$176K 0.03% 140
2024
Q2
$239K Buy
+929
New +$249K 0.01% 191
2024
Q1
Sell
-892
Closed -$235K 211
2023
Q4
$235K Buy
+892
New +$202K 0.02% 178
2022
Q1
Sell
-893
Closed -$227K 181
2021
Q4
$227K Buy
893
+8
+0.9% +$2.25K 0.02% 170
2021
Q3
$240K Buy
885
+43
+5% +$10.9K 0.03% 149
2021
Q2
$206K Buy
+842
New +$194K 0.02% 154
2020
Q4
Sell
-839
Closed -$211K 157
2020
Q3
$211K Buy
+839
New +$184K 0.04% 126

Other funds holding CRM

Accredited Investors's CRM Position: Q1 2026 in Review

Accredited Investors sold out of Salesforce (CRM) in Q1 2026, closing a stake of 1,192 shares — an estimated $316K sold.

Accredited Investors first reported a position in CRM in Q3 2020 and held it in 12 quarters. The position peaked at $443K in Q3 2024. 2,682 funds tracked by Wall St. Rank hold CRM as of Q1 2026.

  • Accredited Investors reported no remaining Salesforce position as of Q1 2026 after selling out during the quarter.
  • Accredited Investors sold 1,192 Salesforce shares in Q1 2026, an estimated $316K.
  • Accredited Investors first reported a position in Salesforce in Q3 2020 and held it in 12 quarters.
  • Accredited Investors's Salesforce position peaked at $443K in Q3 2024.
  • 2,682 funds tracked by Wall St. Rank held Salesforce as of Q1 2026.

Based on Accredited Investors's 13F filing for Q1 2026, filed 30 Apr 2026.